文献速递免疫规划卫生政策与健康促进

新冠不同疫苗资源分配:有效性与覆盖面的权衡与协同

Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
PubMed 文献 · Vaccine · 2021-10-18

研究扩展SIR-D模型模拟不同资源分配下两种疫苗(早上市高效苗vs晚上市低效苗)的感染 attack rate(IAR)。发现资源有限时,若早上市高效苗覆盖人群不足42.5%(特定参数下),优先分配资源给高效苗不一定降低IAR;低资源需求(广覆盖)疫苗即使上市晚也能显著降低IAR。

要点

  • 资源有限时,高效早上市疫苗若覆盖不足42.5%人群,优先分配不一定降低IAR。
  • 低资源需求、广覆盖的疫苗即使上市较晚也能显著降低感染 attack rate。
  • 疫苗分配决策需权衡有效性与覆盖面,而非仅追求高效疫苗。

核心结论

  • 资源有限时,将资源分配给早上市高效疫苗并不总是降低IAR,尤其当其覆盖人群低于42.5%时。
  • 低资源需求(广覆盖)的疫苗即使上市较晚,也能显著降低IAR。

研究设计与样本

  • 扩展带疫苗接种的易感-感染-康复-死亡(SIR-D)模型,进行不同设置下的广泛模拟,比较两种疫苗不同覆盖比下的IAR。

主要发现

  • 早上市高效疫苗覆盖不足42.5%人群时,优先分配资源给该疫苗不一定降低IAR。
  • 敏感性分析显示该结果在不同研究参数下稳健。

关键数值与推荐

  • 早上市高效疫苗可覆盖人群低于42.5%(特定研究参数下)时,优先分配不一定降低IAR。

临床怎么用

  • 疫苗分配决策应综合考虑有效性与覆盖面,避免仅追求高效疫苗而忽视覆盖能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Vaccine shortage and supply-chain challenges have caused limited access by many resource-limited countries during the COVID-19 pandemic. One of the primary decisions for a vaccine-ordering decision-maker is how to allocate the limited resources between different types of vaccines effectively. We studied the tradeoff between efficacy and reach of the two vaccine types that become available at different times. METHODS: We extended a Susceptible-Infected-Recovered-Deceased (SIR-D) model with vaccination, ran extensive simulations with different settings, and compared the level of infection attack rate (IAR) under different reach ratios between two vaccine types under different resource allocation decisions. RESULTS: We found that when there were limited resources, allocating resources to a vaccine with high efficacy that became available earlier than a vaccine with lower efficacy did not always lead to a lower IAR, particularly if the former could vaccinate less than 42.5% of the population (with the selected study parameters) who could have received the latter. Sensitivity analyses showed that this result stayed robust under different study parameters. CONCLUSIONS: Our results showed that a vaccine with lower resource requirements (wider reach) can significantly contribute to reducing IAR, even if it becomes available later in the pandemic, compared to a higher efficacy vaccine that becomes available earlier but requires more resources. Limited resource in vaccine distribution is significant challenge in many parts of the world that needs to be addressed to improve the global access to life-saving vaccines. Understanding the tradeoffs between efficacy and reach is critical for resource allocation decisions between different vaccine types for improving health outcomes.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kim D, Pekgün P, Yildirim İ, et al. Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach. Vaccine. 2021. PMID: 34688498. doi:10.1016/j.vaccine.2021.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。